Xi’an-based Our United Corporation has announced that its medical electronic linear accelerator has been approved by the National Medical Products Administration (NMPA) as an innovative medical device. This marks a significant milestone for the company and the field of radiation therapy in China.
Comprehensive Features of the Linear Accelerator
The product, the first of its kind in China, is a comprehensive system consisting of a rack, beam generation module, beam shaping module, treatment bed, image guidance system, and control system. It is designed to offer a range of advanced radiotherapy treatments, including image-guided 3D conformal radiotherapy, conformal intensity modulated radiotherapy, volume modulated radiotherapy, and body stereotactic radiotherapy.
Applications in Cancer and Lesion Treatments
The linear accelerator is intended for the treatment of solid tumors and lesions that are suitable for radiation therapy within the human body. Its approval by the NMPA signifies the recognition of the device’s innovation and potential impact on improving cancer treatment outcomes.-Fineline Info & Tech
